Search Results - "Gerety, Gregg"
-
1
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (11-01-2022)“…IMPORTANCE: Phase 3 trials have not compared semaglutide and liraglutide, glucagon-like peptide-1 analogues available for weight management. OBJECTIVE: To…”
Get full text
Journal Article -
2
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (04-07-2017)“…IMPORTANCE: Hypoglycemia, common in patients with type 1 diabetes, is a major barrier to achieving good glycemic control. Severe hypoglycemia can lead to coma…”
Get full text
Journal Article -
3
Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes—Reply
Published in JAMA : the journal of the American Medical Association (14-11-2017)Get full text
Journal Article -
4
NASAL GLUCAGON DELIVERY IS MORE SUCCESSFUL THAN INJECTABLE DELIVERY: A SIMULATED SEVERE HYPOGLYCEMIA RESCUE
Published in Endocrine practice (01-04-2020)“…A severe hypoglycemia (SH) episode is an acute, high-stress moment for the caregivers of persons with diabetes (PWD). We compared the success rates of nasal…”
Get more information
Journal Article -
5
Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting
Published in Diabetes, obesity & metabolism (01-05-2018)“…In the present multicentre, open‐label, prospective, phase III study, we evaluated the real‐world effectiveness and ease of use of nasal glucagon (NG) in the…”
Get full text
Journal Article -
6
Day‐to‐day fasting self‐monitored blood glucose variability is associated with risk of hypoglycaemia in insulin‐treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials
Published in Diabetes, obesity & metabolism (01-03-2019)“…Aims To investigate the association between day‐to‐day fasting self‐monitored blood glucose (SMBG) variability and risk of hypoglycaemia in type 1 (T1D) and…”
Get full text
Journal Article -
7
TREATMENT INTENSIFICATION WITH INSULIN DEGLUDEC/INSULIN ASPART TWICE DAILY: RANDOMIZED STUDY TO COMPARE SIMPLE AND STEP-WISE TITRATION ALGORITHMS
Published in Endocrine practice (01-05-2016)“…This 26-week, multicenter, randomized, open-label, parallel-group, treat-to-target trial in adults with type 2 diabetes compared the efficacy and safety of…”
Get more information
Journal Article -
8
-
9
-
10
-
11